wr 242511 has been researched along with alsterpaullone in 1 studies
| Studies (wr 242511) | Trials (wr 242511) | Recent Studies (post-2010) (wr 242511) | Studies (alsterpaullone) | Trials (alsterpaullone) | Recent Studies (post-2010) (alsterpaullone) |
|---|---|---|---|---|---|
| 11 | 0 | 0 | 80 | 0 | 31 |
| Protein | Taxonomy | wr 242511 (IC50) | alsterpaullone (IC50) |
|---|---|---|---|
| Chain A, Glycogen Synthase Kinase-3 Beta | Homo sapiens (human) | 0.004 | |
| Chain B, Glycogen Synthase Kinase-3 Beta | Homo sapiens (human) | 0.004 | |
| Chain A, Glycogen Synthase Kinase-3 Beta | Homo sapiens (human) | 0.004 | |
| G2/mitotic-specific cyclin-B2 | Homo sapiens (human) | 0.035 | |
| Cyclin-dependent kinase 1 | Homo sapiens (human) | 0.0321 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 1.5 | |
| G2/mitotic-specific cyclin-B1 | Homo sapiens (human) | 0.035 | |
| G2/mitotic-specific cyclin-B | Marthasterias glacialis (spiny starfish) | 0.0263 | |
| Glycogen synthase kinase-3 beta | Rattus norvegicus (Norway rat) | 0.0263 | |
| Cyclin-A2 | Homo sapiens (human) | 0.015 | |
| Cyclin-dependent kinase 2 | Homo sapiens (human) | 0.015 | |
| Glycogen synthase kinase-3 alpha | Homo sapiens (human) | 0.0043 | |
| Glycogen synthase kinase-3 beta | Homo sapiens (human) | 0.0105 | |
| Cyclin-dependent-like kinase 5 | Homo sapiens (human) | 0.0608 | |
| Cyclin-dependent kinase 5 activator 1 | Homo sapiens (human) | 0.0815 | |
| G2/mitotic-specific cyclin-B3 | Homo sapiens (human) | 0.035 | |
| Cyclin-dependent kinase 1 | Oryzias latipes (Japanese medaka) | 0.0263 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
1 other study(ies) available for wr 242511 and alsterpaullone
| Article | Year |
|---|---|
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |